Drug Trial Radar · NCT05768854
Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta
Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
69
Actual
Start
Jun 14, 2023
Primary completion
Oct 23, 2025
Study completion Apr 2027
Sponsor
- Lead sponsor
- Ultragenyx Pharmaceutical IncIndustry
- Sponsor type
- Industry
- First posted
- Mar 14, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 6 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study is to evaluate the effect of setrusumab vs intravenous bisphosphonates (IV-BP) on reduction in fracture rate, including morphometric vertebral fractures in pediatric participants.
Conditions
- Osteogenesis Imperfecta
Interventions
BisphosphonateDrug
Administered per investigator discretion via intravenous (IV) infusion
SetrusumabBiological
A fully human sclerostin neutralizing monoclonal antibody (mAb) administered once a month (QM) via intravenous (IV) infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized Rate of All Radiographically-Confirmed Fractures, Including Morphometric Vertebral Fractures, at the Primary AnalysisTime frame: Up to 24 Months
Locations
20 sites in 7 countries. Site status is shown where the registry gives one.
Phoenix Children's Hospital
Phoenix, Arizona
Childrens Hospital LA
Los Angeles, California
Children's Hospital Colorado
Aurora, Colorado
Yale New Haven Hospital
New Haven, Connecticut
Nemours/ Alfred i. duPoint Hospital for Children
Wilmington, Delaware
Children's National Hospital DC
Washington D.C., District of Columbia
University of South Florida
Tampa, Florida
Shriners Hospitals for Children Chicago
Chicago, Illinois
Washington University School of Medicine
St Louis, Missouri
University of North Carolina at Chapel Hill (UNC)
Chapel Hill, North Carolina
Vanderbilt University Medical Center (VUMC)
Nashville, Tennessee
Cook Children's Medical Center
Fort Worth, Texas
Baylor College of Medicine
Houston, Texas
Hospital de Clinicas de Porto Alegre (HCPA)
Porto Alegre, Rio Grande do Sul, Brazil
Childrens Hospital Of Eastern Ontario Research Institute, University Of Ottawa
Ottawa, Canada
Children's Hospital at London Health Sciences Centre
London, Ontario, Canada
Institut Imagine
Paris, France
Azienda Ospedaliera Universitaria Policlinico Umberto I
Roma, Italy
Universitair Medisch Centrum Utrecht (UMCU) - Wilhelmina Kinderziekenhuis
Utrecht, Netherlands
Uniwersytet Medyczny w Lodzi - Klinika Endokrynologii i Chorob Metabolicznych
Lodz, Poland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.